Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Breast 1

Conditions

Breast Neoplasms 96Inflammatory Breast Neoplasms 9Carcinoma, Intraductal, Noninfiltrating 8Breast Neoplasms, Male 6Breast Carcinoma In Situ 6Neoplasm Metastasis 4Triple Negative Breast Neoplasms 3Neoplasms 3Locally Advanced Breast Cancer 2HER2-positive Breast Cancer 2Colorectal Neoplasms 2Breast Cancer Patients 2Stress, Psychological 1Postoperative Complications 1Pathologic Complete Response 1Neovascularization, Pathologic 1Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer 1Motor Activity 1Margins of Excision 1Inflammation 1Infertility 1High-Risk Cancer 1Head and Neck Neoplasms 1Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer 1Colonic Neoplasms 1Cardiotoxicity 1Carcinoma, Lobular 1Breast Cancer-specific Survival 1Breast Cancer Metastatic 1Breast Cancer Invasive 1

Interventions

Trastuzumab 8Doxorubicin 8Exercise 6Cyclophosphamide 6Echocardiography 5Carvedilol 5Docetaxel 4Tablets 2Silymarin 2Radiotherapy 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Exercise Test 2Epirubicin 2Bisoprolol 2Atorvastatin 2Anthracyclines 2sacubitril and valsartan sodium hydrate drug combination 1nicotinamide-beta-riboside 1mitoquinone 1epicatechin gallate 1empagliflozin 1dapagliflozin 1candesartan 1Watchful Waiting 1Therapeutics 1Taxes 1Tamoxifen 1Social Determinants of Health 1Secondary Prevention 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiotoxicity × Neoadjuvant Therapy × Breast × Clear all
NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
800 enrolled
Breast

Breast Neoplasms, Postoperative Complications, Breast Neoplasms, Male, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡